Innoviva (INVA) Tax Rate (2014 - 2026)
Innoviva's (INVA) quarterly Tax Rate came in at 20.45% in Q1 2026, up 4118.0% YoY from 0.48% in Q1 2025, and up 8.7% on a QoQ basis from 18.81% in Q3 2025.
Powered by 
Analysis
Innoviva (INVA) Tax Rate (2014 - 2026) Analysis & Trends
Innoviva (INVA) has 11 years of Tax Rate data on file, last reported at 20.45% in Q1 2026.
- Quarterly Tax Rate rose 4118.0% year-over-year to 20.45% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 21.26% (up 2946.0% YoY) and the FY2024 annual result came in at 102357.69%, up 10235695.0% from the prior year.
- Tax Rate advanced to 20.45% in Q1 2026, from 18.81% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 77.52% in Q2 2023 to a low of 20.73% in Q1 2025.
- A 5-year average of 20.77% and a median of 15.34% in 2022 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2023 — Tax Rate soared 8191 bps — and 2024, when it plunged 6582 bps.
- Tracing INVA's Tax Rate over 5 years: stood at 17.93% in 2022, then tumbled by 38 bps to 11.07% in 2023, then jumped by 583 bps to 75.63% in 2024, then sank by 75 bps to 18.81% in 2025, then grew by 9 bps to 20.45% in 2026.
- The last three Tax Rate figures came in at 20.45% (Q1 2026), 18.81% (Q3 2025), and 12.27% (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.71% |
| 10 | Innoviva | 1.56 Bn | 984.81 Mn | 90.62 Mn | 22.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.77% |
| Mar 31, 2026 | 20.46% |
| Sep 30, 2025 | 18.82% |
| Jun 30, 2025 | 12.27% |
| Mar 31, 2025 | -20.73% |
| Sep 30, 2024 | 75.89% |
| Jun 30, 2024 | 11.71% |
| Mar 31, 2024 | 19.06% |
| Sep 30, 2023 | 11.07% |
| Jun 30, 2023 | 77.95% |
| Mar 31, 2023 | 15.31% |
| Sep 30, 2022 | 17.94% |
| Jun 30, 2022 | -4.39% |
| Mar 31, 2022 | 15.43% |
| Sep 30, 2021 | 16.87% |
| Jun 30, 2021 | 18.60% |
| Mar 31, 2021 | 15.25% |
| Dec 31, 2020 | 32.72% |
| Sep 30, 2020 | 17.63% |
| Jun 30, 2020 | 16.85% |